Literature DB >> 24914967

Structure of the phosphotransferase domain of the bifunctional aminoglycoside-resistance enzyme AAC(6')-Ie-APH(2'')-Ia.

Clyde A Smith1, Marta Toth2, Monolekha Bhattacharya2, Hilary Frase2, Sergei B Vakulenko2.   

Abstract

The bifunctional acetyltransferase(6')-Ie-phosphotransferase(2'')-Ia [AAC(6')-Ie-APH(2'')-Ia] is the most important aminoglycoside-resistance enzyme in Gram-positive bacteria, conferring resistance to almost all known aminoglycoside antibiotics in clinical use. Owing to its importance, this enzyme has been the focus of intensive research since its isolation in the mid-1980s but, despite much effort, structural details of AAC(6')-Ie-APH(2'')-Ia have remained elusive. The structure of the Mg2GDP complex of the APH(2'')-Ia domain of the bifunctional enzyme has now been determined at 2.3 Å resolution. The structure of APH(2'')-Ia is reminiscent of the structures of other aminoglycoside phosphotransferases, having a two-domain architecture with the nucleotide-binding site located at the junction of the two domains. Unlike the previously characterized APH(2'')-IIa and APH(2'')-IVa enzymes, which are capable of utilizing both ATP and GTP as the phosphate donors, APH(2'')-Ia uses GTP exclusively in the phosphorylation of the aminoglycoside antibiotics, and in this regard closely resembles the GTP-dependent APH(2'')-IIIa enzyme. In APH(2'')-Ia this GTP selectivity is governed by the presence of a `gatekeeper' residue, Tyr100, the side chain of which projects into the active site and effectively blocks access to the adenine-binding template. Mutation of this tyrosine residue to a less bulky phenylalanine provides better access for ATP to the NTP-binding template and converts APH(2'')-Ia into a dual-specificity enzyme.

Entities:  

Keywords:  AAC(6′)-Ie-APH(2′′)-Ia; aminoglycoside-resistance enzymes

Mesh:

Substances:

Year:  2014        PMID: 24914967      PMCID: PMC4051501          DOI: 10.1107/S1399004714005331

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  57 in total

1.  GTP plus water mimic ATP in the active site of protein kinase CK2.

Authors:  K Niefind; M Pütter; B Guerra; O G Issinger; D Schomburg
Journal:  Nat Struct Biol       Date:  1999-12

2.  Structural analyses of nucleotide binding to an aminoglycoside phosphotransferase.

Authors:  D L Burk; W C Hon; A K Leung; A M Berghuis
Journal:  Biochemistry       Date:  2001-07-31       Impact factor: 3.162

3.  Domain-domain interactions in the aminoglycoside antibiotic resistance enzyme AAC(6')-APH(2'').

Authors:  David D Boehr; Denis M Daigle; Gerard D Wright
Journal:  Biochemistry       Date:  2004-08-03       Impact factor: 3.162

4.  A small molecule discrimination map of the antibiotic resistance kinome.

Authors:  Tushar Shakya; Peter J Stogios; Nicholas Waglechner; Elena Evdokimova; Linda Ejim; Jan E Blanchard; Andrew G McArthur; Alexei Savchenko; Gerard D Wright
Journal:  Chem Biol       Date:  2011-12-23

5.  Aminoglycoside 2''-phosphotransferase IIIa (APH(2'')-IIIa) prefers GTP over ATP: structural templates for nucleotide recognition in the bacterial aminoglycoside-2'' kinases.

Authors:  Clyde A Smith; Marta Toth; Hilary Frase; Laura J Byrnes; Sergei B Vakulenko
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

6.  Phosphotransferase sequence homology.

Authors:  S Brenner
Journal:  Nature       Date:  1987 Sep 3-9       Impact factor: 49.962

7.  Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site.

Authors:  Beatriz Llano-Sotelo; Eduardo F Azucena; Lakshmi P Kotra; Shahriar Mobashery; Christine S Chow
Journal:  Chem Biol       Date:  2002-04

8.  The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups.

Authors:  G H Miller; F J Sabatelli; R S Hare; Y Glupczynski; P Mackey; D Shlaes; K Shimizu; K J Shaw
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

9.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

Review 10.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14
View more
  7 in total

1.  Structure of the bifunctional aminoglycoside-resistance enzyme AAC(6')-Ie-APH(2'')-Ia revealed by crystallographic and small-angle X-ray scattering analysis.

Authors:  Clyde A Smith; Marta Toth; Thomas M Weiss; Hilary Frase; Sergei B Vakulenko
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-09-27

2.  Expanding Aminoglycoside Resistance Enzyme Regiospecificity by Mutation and Truncation.

Authors:  Selina Y L Holbrook; Sylvie Garneau-Tsodikova
Journal:  Biochemistry       Date:  2016-09-26       Impact factor: 3.162

3.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597

4.  Structural basis for the diversity of the mechanism of nucleotide hydrolysis by the aminoglycoside-2''-phosphotransferases.

Authors:  Clyde A Smith; Marta Toth; Nichole K Stewart; Lauren Maltz; Sergei B Vakulenko
Journal:  Acta Crystallogr D Struct Biol       Date:  2019-11-29       Impact factor: 7.652

Review 5.  Amikacin: Uses, Resistance, and Prospects for Inhibition.

Authors:  Maria S Ramirez; Marcelo E Tolmasky
Journal:  Molecules       Date:  2017-12-19       Impact factor: 4.411

Review 6.  Structure and Functional Diversity of GCN5-Related N-Acetyltransferases (GNAT).

Authors:  Abu Iftiaf Md Salah Ud-Din; Alexandra Tikhomirova; Anna Roujeinikova
Journal:  Int J Mol Sci       Date:  2016-06-28       Impact factor: 5.923

7.  Discovery of a novel integron-borne aminoglycoside resistance gene present in clinical pathogens by screening environmental bacterial communities.

Authors:  Maria-Elisabeth Böhm; Mohammad Razavi; Nachiket P Marathe; Carl-Fredrik Flach; D G Joakim Larsson
Journal:  Microbiome       Date:  2020-03-20       Impact factor: 14.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.